News · Recognition · Public conversation
Signals from the lab

Discovery,
in motion.

New mechanisms, new tools, and new recognition—follow the ideas shaping our program in spatial immunology and therapeutic cell engineering.

2026A founding year at Penn
Selected milestones

The work,
as it unfolds.

Publication2026
Nature

KLHL6 reveals a proteostasis checkpoint for CD8+ T-cell dysfunction

A convergent analysis across 136 datasets identifies a mechanism linking exhaustion resistance, mitochondrial fitness, and antitumor function.

01Read more ↗
Publication2026
Nature Communications

Sequential transcriptional waves direct drug-induced cancer dedifferentiation

Temporal multi-omic analysis resolves how NF-κB-driven chromatin remodeling reshapes cell identity and drug response.

02Read more ↗
Honor2025
Allen Institute

Yapeng Su named a Next Generation Leader

Recognition for emerging leadership at the intersection of systems immunology, quantitative biology, and therapeutic cell engineering.

03Read more ↗
Publication2025
PNAS

A synthetic receptor converts TGF-β suppression into IL-2 survival signaling

The receptor recodes a hostile tumor cue to sustain engineered T-cell activation.

04Read more ↗
Publication2025
Cancer Cell

Mannose exposure installs a stem-like program in therapeutic T cells

Metabolic, transcriptional, and epigenetic profiling connects pre-infusion conditioning to durable antitumor function.

05Read more ↗
Funding + honor2024
NIH / STAT

Pathway to independence and a STAT Wunderkind

An NIH/NCI K99–R00 award and STAT Wunderkind recognition accelerate an independent program in T-cell fate engineering.

06Read more ↗
Publication2022
Cell

Longitudinal systems immunology reveals early factors associated with long COVID

A multi-omic study connects acute-phase biology to later post-acute sequelae and sparks broad public discussion.

07Read more ↗
Publication2022
Nature Biotechnology

A systems view of immune responses to COVID-19

High-dimensional immune profiling links cell states, molecular programs, and clinical trajectories.

08Read more ↗
In the public conversation

Science that
travels.

The long-COVID systems study reached audiences through national and international reporting—carrying multi-omic science beyond the scientific literature.

THE NEXT SIGNAL

New lab.
New questions.
Watch this space.

Join the Su Lab ↗